US4076841A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides
Assignee: Dow Chemical Co
•
Filing: 1977-03-04
•
Granted: 1978-02-28
•
Expires: 1997-03-04
Abstract
Abstract Novel 2-((3,5-di-tert-butyl-4-hydroxyphenyl)-thio)carboxamides and compositions containing the compounds are disclosed. A method for reducing blood serum lipids using the compounds and compositions of the invention is also disclosed.
Inventors
- 👤 Eugene R. Wagner
- 👤 Larry G. Mueller
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 23:40
CPC Classifications
C; C07; C07D; C07D211/00; C07D211/04; C07D211/06; C07D211/36; C07D211/60; C07D211/62
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
20 words
A compound of the formula: ##STR3## wherein R 1 and R 2 independently represent hydrogen, lower alkyl, or lower hydroxyalkyl.
Claim 2
Dependent Claim
20 words
A compound of the formula: ##STR3## wherein R 1 and R 2 independently represent hydrogen, lower alkyl, or lower hydroxyalkyl.
Claim 3
Dependent Claim
8 words
The compound of claim 1 which is 2-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)thio)-N,N-dimethylhexanamide.
Claim 4
Dependent Claim
8 words
The compound of claim 1 which is 2-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)thio)-N-(2-hydroxy)ethylhexanamide.
Claim 5
Independent Claim
42 words
A method for lowering elevated serum lipids in a mammal which comprises administering internally to the mammal a hypolipidemically effective amount of a compound of the formula: ##STR4## wherein R 1 and R 2 independently represent hydrogen, lower alkyl, or lower hydroxyalkyl.
Claim 6
Independent Claim
42 words
A method for lowering elevated serum lipids in a mammal which comprises administering internally to the mammal a hypolipidemically effective amount of a compound of the formula: ##STR4## wherein R 1 and R 2 independently represent hydrogen, lower alkyl, or lower hydroxyalkyl.
Claim 7
Dependent Claim
20 words
The method of claim 4 wherein the mammal is administered 5 mg/kg to 30 mg/kg body weight of the compound.
Claim 8
Dependent Claim
10 words
The method of claim 4 wherein the compound is 2-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)thio)-N,N-dimethylhexanamide.
Claim 9
Dependent Claim
10 words
The method of claim 4 wherein the compound is 2-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)thio-N-(2-hydroxy)ethylhexanamide.
Claim 10
Dependent Claim
34 words
A hypolipidemic composition comprising a suitable pharmaceutical carrier and a hypolipidemically effective amount of a compound having the formula: ##STR5## wherein R 1 and R 2 independently represent hydrogen, lower alkyl, or lower hydroxyalkyl.
Claim 11
Dependent Claim
34 words
A hypolipidemic composition comprising a suitable pharmaceutical carrier and a hypolipidemically effective amount of a compound having the formula: ##STR5## wherein R 1 and R 2 independently represent hydrogen, lower alkyl, or lower hydroxyalkyl.
Claim 12
Dependent Claim
10 words
The composition of claim 8 wherein the compound is 2-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)thio-N,N-dimethylhexanamide
Claim 13
Dependent Claim
10 words
The composition of claim 8 wherein the compound is 2-(3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)thio-N-(2-hydroxy)ethylhexanamide.
References Cited (Backward Citations)
US3927092A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-02-27 | 1981-08-29 | 1982-02-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-02-27 | 1985-08-29 | 1986-02-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-02-27 | 1989-08-29 | 1990-02-28 | $7700.00 | Window Closed / Lapsed |